Solid Biosciences Inc (SLDB)
3.20 x 20 3.30 x 13
Post-market by (Cboe BZX)
3.23 -0.07 (-2.12%) 04/28/25 [NASDAQ]
3.20 x 20 3.30 x 13
Post-market 3.30 +0.07 (+2.17%) 16:25 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | SLDB | VNDA | AVIR | ||
Company | Solid Biosciences Inc | Vanda Pharmaceuticals | Atea Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 3.30 | 4.26 | 2.87 | ||
High | 3.43 | 4.32 | 2.99 | ||
Low | 3.21 | 4.22 | 2.87 | ||
Last | 3.23 | 4.30 | 2.96 | ||
Change | -0.07 | +0.05 | +0.07 | ||
% Change | -2.12% | +1.18% | +2.42% | ||
Volume | 675,200 | 446,000 | 220,700 | ||
20-Day Average Volume | 1,410,810 | 698,375 | 410,220 | ||
Previous Close | 3.30 | 4.25 | 2.89 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 3.09 | 4.30 | 2.85 | ||
20-Day Raw Stochastic | 48.75% | 50.90% | 63.16% | ||
20-Day Relative Strength | 44.36% | 44.36% | 50.63% | ||
Weighted Alpha | -79.98 | -15.87 | -24.31 | ||
Today's Opinion | 72% Sell | 96% Sell | 88% Sell | ||
Previous Opinion | 72% Sell | 100% Sell | 88% Sell | ||
Last Month's Opinion | 56% Sell | 64% Sell | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +6.60% since 04/21/25 | +0.23% since 04/21/25 | +3.50% since 04/21/25 | ||
Low | 3.05 on 04/22/25 | 4.20 on 04/25/25 | 2.78 on 04/24/25 | ||
High | 3.75 on 04/23/25 | 4.49 on 04/23/25 | 2.99 on 04/28/25 | ||
1-Month | |||||
%Chg | -25.23% since 03/28/25 | -8.32% since 03/28/25 | +1.02% since 03/28/25 | ||
Low | 2.45 on 04/17/25 | 3.85 on 04/09/25 | 2.60 on 04/10/25 | ||
High | 4.05 on 03/31/25 | 4.73 on 03/31/25 | 3.17 on 04/17/25 | ||
3-Month | |||||
%Chg | -1.52% since 01/28/25 | -3.15% since 01/28/25 | -4.52% since 01/28/25 | ||
Low | 2.45 on 04/17/25 | 3.85 on 04/09/25 | 2.60 on 04/10/25 | ||
High | 7.20 on 02/18/25 | 5.19 on 03/06/25 | 3.29 on 03/24/25 | ||
6-Month | |||||
%Chg | -44.60% since 10/28/24 | -10.04% since 10/28/24 | -13.45% since 10/28/24 | ||
Low | 2.45 on 04/17/25 | 3.85 on 04/09/25 | 2.60 on 04/10/25 | ||
High | 7.20 on 02/18/25 | 5.55 on 11/12/24 | 3.62 on 11/06/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 241,391 | 241,428 | 238,615 | ||
Shares Outstanding, K | 77,493 | 58,316 | 85,525 | ||
Annual Sales | 0 | 198,770,000 | 0 | ||
Annual Net Income | -124,700,000 | -18,900,000 | -168,390,000 | ||
Last Quarter Sales | 0 | 53,190,000 | 0 | ||
Last Quarter Net Income | -42,600,000 | -4,910,000 | -33,540,000 | ||
60-Month Beta | 2.07 | 0.72 | 0.17 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.89 on 03/06/25 | -0.08 on 02/13/25 | -0.40 on 03/06/25 | ||
Latest Earnings Date | 05/21/25 | 05/14/25 | 05/13/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |